GSK – Egypt posts lower profit in Q1 2021

Updated 6/16/2021 3:44:00 PM

ArabFinance:  GlaxoSmithKline (GSK – Egypt) (BIOC) reports a consolidated net profit of EGP 2.697 million in Q1 2021, compared to EGP 23.142 million, according to the company’s filing to the Egyptian Exchange.

GSK- Egypt posted a standalone net profit of EGP 22.21 million in Q1 2021, compared to EGP 31.9 million in Q1 2021.

The company’s ordinary general assembly approved on May 26th the annual cash dividends of EGP 0.50 per share for 2020.

GSK Egypt, a member of the British pharmaceutical company Glaxo Group, is an Egypt-based company engaged in the manufacture, packaging, marketing, sale, and distribution of pharmaceutical products.